Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Home
Amber Wezenaar

Amber Wezenaar

PhD student

Rios group

Unraveling behavior and efficacy of engineered T cells for the treatment of cancer using 3D imaging and organoid technology.

Phone 088 97 27 680

Email a.k.l.wezenaar@prinsesmaximacentrum.nl

Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma
- jan. 2023
- Jeff, DeMartino, et al
- Nature communications
Uncovering the mode of action of engineered T cells in patient cancer organoids
- jan. 2022
- Johanna F., Dekkers, et al
- Nature Biotechnology

View all publications

Amber Wezenaar

Publications

Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma

Uncovering the mode of action of engineered T cells in patient cancer organoids